treatment

US: Gilead CEO insists federal government patent for HIV prevention pill Truvada is invalid

The chief executive of Gilead Sciences, the nation’s leading manufacturer of HIV drugs, defended the high cost of a key drug that prevents the lethal infection, telling a House committee Thursday that its hefty profits pay for continued research.

Risk of HIV transmission through condomless sex in serodifferent gay couples

Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

UNAIDS welcomes additional evidence that effective antiretroviral therapy stops transmission of HIV

Results from a large-scale European study among serodiscordant gay couples show that adherence to effective treatment prevents transmission of HIV